Frequency, pattern and predictors of cognitive impairments in patients with Parkinson's disease using the Community Screening Instrument for Dementia

被引:0
作者
Ogbimi, Ewere Marie [1 ,2 ]
Akemokwe, Fatai Momodu [1 ,3 ]
Ogunrin, Olubunmi [1 ,4 ]
机构
[1] Univ Benin Teaching Hosp, Dept Med, Neurol Unit, Benin, Nigeria
[2] Delta State Univ, Dept Med, Neurol Unit, Abraka, Nigeria
[3] Univ Kentucky, Dept Neurol, Lexington, KY USA
[4] Royal Stoke Univ Hosp, Neurol Dept, Neurosci Directorate, Stoke On Trent, England
来源
FRONTIERS IN HUMAN NEUROSCIENCE | 2023年 / 17卷
关键词
apraxia; cognition; memory; Nigeria; Parkinson's disease; CSID; DIAGNOSTIC-CRITERIA; PREVALENCE; DYSFUNCTION; AGE; RISK; PD; DISORDERS; NIGERIANS; INTERVIEW; AFRICAN;
D O I
10.3389/fnhum.2023.1126526
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BackgroundParkinson's disease (PD) is a chronic neurodegenerative disorder complicated by cognitive dysfunctions which are associated with increased caregiver burden, pressure on community health facilities, and mortality in affected patients. Most of the data concerning cognitive dysfunctions in PD are from studies conducted in Europe and North America, but there is paucity of data from Sub-Saharan Africa. ObjectiveThe objective of this study is to determine the frequency, pattern and predictors of cognitive impairments amongst patients with Parkinson's disease. Materials and methodsThis was a cross sectional case control study carried out at a tertiary health facility in South-south Nigeria. Participants with PD were consecutively recruited from the neurology outpatient clinics. Demographic and disease-specific data were obtained with the use of a pre-tested questionnaire. Cognitive performance of thirty patients with PD were compared with thirty demographically matched controls using the Community Screening Instrument for Dementia (CSID). CSID was already validated among Nigerians. ResultsThe frequency of cognitive impairment using the CSID was 50% for PD patients (3.3% for controls). Poor cognitive performance was observed across several cognitive domains including language, executive dysfunction, psychomotor speed, and constructional apraxia among PD patients. The independent predictors of the overall cognitive impairment in patients with PD determined by logistic regression analysis include recall deficiency (p = 0.007), impairment with naming (p = 0.044), apraxia (p = 0.003), Hoen & Yahr staging (p = 0.046), UPDRS score (p = 0.015) and age at presentation (p = 0.014). ConclusionCognitive impairments occur more frequently in patients with PD compared to controls. This study also demonstrated the predictive role of severity of disease based on Hoehn & Yahr staging and UPDRS score, and presence of recall deficiency, poor naming ability and apraxia.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Use of memantine (akatinol) for the correction of cognitive impairments in parkinson's disease complicated by dementia
    Litvinenko I.V.
    Odinak M.M.
    Mogil'Naya V.I.
    Perstnev S.V.
    Neuroscience and Behavioral Physiology, 2010, 40 (2) : 149 - 155
  • [22] Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment
    Simon-Gozalbo, Ana
    Rodriguez-Blazquez, Carmen
    Forjaz, Maria J.
    Martinez-Martin, Pablo
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [23] Cognitive changes in Parkinson's disease patients with visual hallucinations
    Ramirez-Ruiz, Blanca
    Junque, Carme
    Marti, Maria-Jose
    Valldeoriola, Francesc
    Tolosa, Eduardo
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 23 (05) : 281 - 288
  • [24] Objective sleep data as predictors of cognitive decline in dementia with Lewy Bodies and Parkinson's disease
    Bugalho, Paulo
    Magrico, Marta
    Alves, Luisa
    Borbinha, Claudia
    SLEEP MEDICINE, 2021, 80 : 273 - 278
  • [25] Relationship Between Cognitive Dysfunction and Behavioural Symptoms in Nigerian Patients with Parkinson's Disease No dementia
    Ojagbemi, Akin
    JOURNAL OF PARKINSONS DISEASE, 2013, 3 (03) : 293 - 300
  • [26] Validity of the Cornell Scale for Depression in Dementia in Parkinson's Disease with and without Cognitive Impairment
    Williams, James R.
    Marsh, Laura
    MOVEMENT DISORDERS, 2009, 24 (03) : 433 - 437
  • [27] DTI Correlates of Distinct Cognitive Impairments in Parkinson's Disease
    Zheng, Zhong
    Shemmassian, Shirag
    Wijekoon, Christopher
    Kim, Won
    Bookheimer, Susan Y.
    Pouratian, Nader
    HUMAN BRAIN MAPPING, 2014, 35 (04) : 1325 - 1333
  • [28] Cognitive impairments in progression of Parkinson's disease
    Stepkina D.A.
    Zakharov V.V.
    Yakhno N.N.
    Neuroscience and Behavioral Physiology, 2010, 40 (1) : 61 - 67
  • [29] Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates
    Orfei, Maria Donata
    Assogna, Francesca
    Pellicano, Clelia
    Pontieri, Francesco Ernesto
    Caltagirone, Carlo
    Pierantozzi, Mariangela
    Stefani, Alessandro
    Spalletta, Gianfranco
    PARKINSONISM & RELATED DISORDERS, 2018, 54 : 62 - 67
  • [30] Effects of amantadine sulfate on cognitive impairments in patients with Parkinson's disease
    Yablonskaya A.Yu.
    Fedorova N.V.
    Belgusheva M.E.
    Neuroscience and Behavioral Physiology, 2011, 41 (6) : 567 - 573